Cite
HARVARD Citation
Ruella, M. et al. (n.d.). Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells. Journal for immunotherapy of cancer. p. . [Online].